Trial Profile
Phase II trial of quizartinib in paediatric patients with acute lymphoblastic leukaemia or acute myeloid leukaemia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Quizartinib (Primary)
- Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 02 May 2014 New trial record